Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aldevron announced its expansion plans for its Freiburg, Germany facility.
read more
Thursday, October 03, 2019
Aldevron has added GMP gene synthesis to its array of services.
read more
Aldevron has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations. This is a new position and is a part of the senior management team.
read more
Wednesday, February 17, 2016
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include ...
read more
Aldevron, has successfully completed the manufacturing of the TUSC2 plasmid DNA pursuant to the manufacturing agreement between Genprex and Aldevron that was announced in September 2018.
read more
Aldevron will expand its mRNA production capabilities to include lipid nanoparticle(LNP) encapsulation and aseptic fill-finish capabilities enabling mRNA cGMP manufacturing services from Master Cell Bank through to Drug Product.
read more
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Tuesday, December 12, 2017
Aldevron announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant which is patented by IDT.
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
Alembic is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level.
read more
PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran ...
read more
Friday, September 15, 2017
Alexion Pharmaceuticals announced an operational plan to re-align the global organization with its refocused corporate strategy, which includes a global workforce reduction by approximately 20 percent.
read more
Wednesday, March 20, 2019
Alexion and Affibody AB announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases.
read more
Alexion Pharmaceuticals and Complement Pharma announced a partnership to co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders.
read more